USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Pharma Clinical Trial Digitization—Companies to Action, 2019
Collision of Healthcare with Life Sciences IT Systems will Continue to Transform the Clinical Trials Market
11-Apr-2019
North America
Market Research
9AB9-00-A6-00-00
HC03161-NA-MR_23016
$1,500.00
Special Price $1,125.00 save 25 %
Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centric and efficient distributed settings. As the clinical trial industry transitions to biomarker-based, targeted therapeutics, it demands a pivotal shift in design focus: from one directed by researchers to one driven by the needs of patients and their caregivers. Frost & Sullivan observes that leading pharmaceutical companies, in particular, are aggressively moving toward the mixed approach of physical and remote clinical trial settings to improve patient engagement and justify the value of future personalized drugs. Furthermore, increasing demand for quality data and novel endpoints demands clinical trial data management solutions to shift from fragmented point solutions that sit in silos to integrated eClinical solutions that provide a single source of truth, optimizing the cost by eliminating duplicate data entry, reducing on-site verification and source data verification rate. This entails an evolving vendor ecosystem of modular cloud-based eClinical solutions with an intuitive user interface capable of integrating all possible study and eSource data to optimize clinical trial digital workflows and data management cost and time.
Research Scope
The research service analyzes the 3 big themes driving clinical trial digitization and the new vendor ecosystem. The study also highlights growth opportunities, case studies of notable market developments, key trends, and investment and collaboration opportunities. Furthermore, the study provides an analysis of major companies segregated by these top 3 themes, which include:
- Digital Continuity Across Clinical Trial IT Systems: Digital continuity provides the framework and transparency required throughout the drug’s lifecycle, from discovery to post approval. Leading clinical trial IT vendors provide propriety or third-party-hosted cloud-based eClinical platforms.
- Patient-centric Remote and Virtual Trial Design: The new pharma era breeds customer centricity, innovation, and engagement with patients, physicians, and all partners in the healthcare ecosystem.
- Direct-to-patient Home Services: Beyond the technological readiness, deployment of remote/virtual clinical trials will heavily rely on DTP clinical supplies and logistics services to meet patients and caregivers where they are.
Companies mentioned in the study are Oracle (ClinicalOne), Medidata Solutions, Science 37, THREAD Research, Evidation Health, ActiGraph, Veeva Systems, Antidote Technologies, Inc., ConsilX, 4G Clinical, CliniOps Inc, CRF, Koneska Health, Aparito, Clinerion, TrialBee, TriNetX Network, PatientsLikeMe, and Deep 6 AI.
Key Issues Addressed
- What are the growth opportunities in clinical trials digitization space? What is the impact of the external environment on this market?
- What are the unique companies that are introducing innovative digital solutions in the market?
- How can companies transform clinical trial operations to provide much-needed patient-centric trials and efficiencies?
- What are the action plans and what is the potential for growth for disruptive and innovative companies in the clinical trials digitization space?
- What is the convergence potential of emerging technologies across the clinical development value chain (such as mHealth, wearables, AI, IoT, and blockchain)?
- How does the future vendor ecosystem for clinical trials look?
Author: Kamaljit Behera
Key Findings
Strategic Imperatives for Key Industry Stakeholders
Top 5 Growth Opportunities
Scope and Segmentation
Key Questions this Study will Answer
Industry Convergence Driving Disruption and Innovation
Frost & Sullivan Companies to Action—Potential to Disrupt Healthcare Industry Paradigms
Technology Convergence Transforming Clinical Trial Models
Market Definition and Segmentation
Clinical Trial IT Market—Major Application Segments and Technologies
Digital Continuity
Challenges and Role of mHealth Solutions
Distributed Clinical Trials Ecosystem—Future Vision (2025)
Top 3 Trends and Vendor Strategies
C2A Targets Aligned with Top 3 Trends
Value Chain Analysis
Clinical Trial Digital Solutions—Analysis of Companies to Action
Clinical One by Oracle
Clinical One by Oracle (continued)
Medidata eClinical Solutions
Medidata eClinical Solutions (continued)
Science 37
Science 37 (continued)
THREAD Research
THREAD Research (continued)
Marken
Marken (continued)
ActiGraph
ActiGraph (continued)
Antidote Technologies, Inc
Antidote Technologies, Inc (continued)
CONSILX
CONSILX (continued)
Short Profiles of Clinical Trial Digital Solutions Companies
Short Profiles of Clinical Trial Digital Solutions Companies (continued)
Short Profiles of Clinical Trial Digital Solutions Companies (continued)
Entry of Non-traditional Participants
Key Conclusions
Legal Disclaimer
List of Abbreviations and Acronyms
Short Capability Matrix of Select Vendors Providing Clinical Trials Digital Solutions
Short Capability Matrix of Select Vendors Providing Clinical Trials Digital Solutions (continued)
Short Capability Matrix of Select Vendors Providing Clinical Trials Digital Solutions (continued)
Select Pharma and mHealth Vendor Collaboration Deals
Select Pharma and mHealth Vendor Collaboration Deals (continued)
Select Pharma and mHealth Vendor Collaboration Deals (continued)
Key Trends
Interested in Full Access? Connect With Us
List of Exhibits
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Scope
The research service analyzes the 3 big themes driving clinical trial digitization and the new vendor ecosystem. The study also highlights growth opportunities, case studies of notable market developments, key trends, and investment and collaboration opportunities. Furthermore, the study provides an analysis of major companies segregated by these top 3 themes, which include:
- Digital Continuity Across Clinical Trial IT Systems
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Kamaljit Behera |
| Industries | Healthcare |
| WIP Number | 9AB9-00-A6-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9562-B1,9571-B1,9573-B1,99C1-B1,99C6-B1,9837-B1,9568-B1,9611-B1,9627-B1 |